| human | Q5 |
| P2456 | DBLP author ID | 46/7925 |
| P6178 | Dimensions author ID | 0772051261.76 |
| P496 | ORCID iD | 0000-0003-1786-5708 |
| P108 | employer | Vrije Universiteit Brussel | Q612665 |
| P735 | given name | Kenno | Q96859605 |
| Kenno | Q96859605 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q37701700 | A Comparative Study of Transferable Aspherical Pseudoatom Databank and Classical Force Fields for Predicting Electrostatic Interactions in Molecular Dimers |
| Q44581055 | Ab initio study of the binding of Trichostatin A (TSA) in the active site of histone deacetylase like protein (HDLP). |
| Q51832334 | Accurate interaction energies at density functional theory level by means of an efficient dispersion correction. |
| Q39290921 | Additive CHARMM force field for naturally occurring modified ribonucleotides |
| Q50910839 | Amphipathic α-helix mimetics based on a 1,2-diphenylacetylene scaffold. |
| Q42199119 | Automation of the CHARMM General Force Field (CGenFF) I: bond perception and atom typing. |
| Q42184293 | Automation of the CHARMM General Force Field (CGenFF) II: assignment of bonded parameters and partial atomic charges. |
| Q34085563 | CHARMM additive all-atom force field for carbohydrate derivatives and its utility in polysaccharide and carbohydrate-protein modeling. |
| Q30365988 | CHARMM additive and polarizable force fields for biophysics and computer-aided drug design |
| Q24632987 | CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields |
| Q36539936 | CHARMM-GUI PDB manipulator for advanced modeling and simulations of proteins containing nonstandard residues. |
| Q57955126 | DFT-based ranking of zinc-binding groups in histone deacetylase inhibitors |
| Q40290997 | Evaluating London Dispersion Interactions in DFT: A Nonlocal Anisotropic Buckingham-Hirshfeld Model |
| Q34347574 | Extension of the CHARMM General Force Field to sulfonyl-containing compounds and its utility in biomolecular simulations. |
| Q41313873 | In silico identification of PAP-1 binding sites in the Kv1.2 potassium channel. |
| Q57955124 | Influence of Stacking on the Hydrogen Bond Donating Potential of Nucleic Bases |
| Q38302930 | Lipid-linked oligosaccharides in membranes sample conformations that facilitate binding to oligosaccharyltransferase |
| Q38129103 | Molecular mechanics |
| Q42386479 | Parametrization of halogen bonds in the CHARMM general force field: Improved treatment of ligand-protein interactions |
| Q30843588 | Perturbation of long-range water dynamics as the mechanism for the antifreeze activity of antifreeze glycoprotein. |
| Q30381449 | Quantifying the Binding Interaction between the Hypoxia-Inducible Transcription Factor and the von Hippel-Lindau Suppressor. |
| Q40975965 | Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma |
| Q39384360 | Relaxation of the rigid backbone of an oligoamide-foldamer-based α-helix mimetic: identification of potent Bcl-xL inhibitors. |
| Q40026039 | Robustness in the fitting of molecular mechanics parameters. |
| Q41451646 | Site-Specific Fragment Identification Guided by Single-Step Free Energy Perturbation Calculations |
| Q24292973 | The novel BH3 α-helix mimetic JY-1-106 induces apoptosis in a subset of cancer cells (lung cancer, colon cancer and mesothelioma) by disrupting Bcl-xL and Mcl-1 protein-protein interactions with Bak |
| Q46849354 | The use of atomic intrinsic polarizabilities in the evaluation of the dispersion energy |
| Q46476773 | Theoretical study revealing the functioning of a novel combination of catalytic motifs in histone deacetylase |
Search more.